Pay in 4 interest-free payments of $272.50 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
ALPPL2 is not only a candidate for therapy development targeting ALPPL2-expressing tumors but has also been identified as a significant surface marker specific to the naive state of pluripotency
and proliferation of epithelial cells
leukocytic endogenous mediator
In different tissues
UniOne® TR-FRET Human IL10/IL10RA Binding Kit Size:500T ALPPL2 is not only aProduct Specification Host Human Stability & Storage 80 Background This kit utilizes HomogeneousTime Resolved Fluorescence (TR FRET) technology to measure the interactionbetween IL10A and IL10RA. This method enables simple and rapid high throughputscreening of inhibitors and antibody blockers. As illustrated, the interactionbetween IL10A and IL10RA is detected using an Eu labeled Anti Tag1 antibody(TR FRET donor) and an Acceptor labeled IL10A protein